tiprankstipranks
Trending News
More News >

Serina Therapeutics Names Steven Ledger as Permanent CEO

Serina Therapeutics Names Steven Ledger as Permanent CEO

Confident Investing Starts Here:

Serina Therapeutics ( (SER) ) just unveiled an update.

Serina Therapeutics, Inc. has solidified its leadership by appointing Steven Ledger as the permanent CEO after his interim tenure. With over 35 years of industry experience, Ledger brings a wealth of knowledge from various advisory and operational roles in early-stage companies and venture capital. His compensation package includes a $450,000 base salary, potential for 50% incentive, and stock options, aligning his interests with the company’s strategic goals. The agreement also contains non-compete and non-solicitation clauses, ensuring Ledger’s commitment to Serina Therapeutics’ success.

See more insights into SER stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App